TRACI ALLISON: Open Payments
NPI 1801448790 · FARMINGTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 64 payments from 26 companies in 2025. Trend: 2023 $282 · 2024 $747 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $205 |
| Supernus Pharmaceuticals, Inc. | 14 | $131 |
| Novo Nordisk Inc | 5 | $82 |
| PFIZER INC. | 4 | $75 |
| Corcept Therapeutics | 3 | $73 |
| ViiV Healthcare Company | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Dexcom, Inc. | 1 | $40 |
Products named: Qelbree, BREZTRI, Korlym, FARXIGA, APRETUDE, Auvelity, AIRSUPRA, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
